ARCHIVES

Celgene Signs CRADA With NCI For Development Of CDC-501.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996

In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches

October 24, 1980

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013